http://bit.do/dLv27 Secret sale page FxMath.
Johnson & Johnson (NYSE:JNJ) reported fiscal Q2 net income of $3.4 billion, or $1.23 per share. Excluding certain items, net earnings for the quarter were $3.4 billion, or $1.21 per share. On average, analysts expected EPS of $1.21. Revenues rose 0.6% year-over-year to $15.3 billion. On average, analysts expected revenues of $15.64 billion. CEO William C. Weldon said, "Our second-quarter results include strong growth in a number of our recently launched products which contributed to solid earnings. Remedial actions to address the product quality issues at McNeil Consumer Healthcare are ongoing and of high importance. At the same time, we continue to make significant investments in acquisitions, strategic partnerships and in advancing our pipeline, positioning us well for future growth." SmarTrend alerted subscribers to take profits in Johnson & Johnson on May 06, 2010 at $62.56, since then the stock fell 4.7%. We are now watching for any positive developments that could result in a new uptrend signal.
